8-K: Sanara MedTech to Present 2026 Strategy at Piper Sandler

Sanara MedTech Inc. will present its 2026 fiscal year priorities and strategy at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025.

Summary

• Sanara MedTech Inc. is furnishing an investor presentation (Exhibit 99.1) via a Form 8-K.
• The presentation will be used in meetings with investors and analysts, including at the Piper Sandler 37th Annual Healthcare Conference in New York, New York.
• The conference presentation is scheduled for December 3, 2025.
• The investor presentation contains a summary of the Company's priorities and strategy for the 2026 fiscal year.
• The information in Item 7.01 and Exhibit 99.1 is furnished, not filed, and is not deemed incorporated by reference into other SEC filings.

Sentiment

Score: 6

Explanation: The filing is a procedural disclosure of an upcoming investor presentation outlining future strategy, which is generally a positive sign of corporate communication and planning. However, it contains no specific financial results or new material information beyond the presentation's existence and general content, leading to a neutral to slightly positive sentiment.

Positives

• Engagement with investors and analysts at a significant industry conference.
• Outlining priorities and strategy for the upcoming 2026 fiscal year, indicating forward planning and transparency.

Future Outlook

The investor presentation will provide a summary of the Company's priorities and strategy for the 2026 fiscal year. The Company has stated it undertakes no duty to publicly update or revise this information, though it may do so as management deems warranted.

Management Comments

• "The Company undertakes no duty or obligation to publicly update or revise the information contained in the Presentation, although it may do so from time to time as its management believes is warranted."

Industry Context

Sanara MedTech's participation in the Piper Sandler 37th Annual Healthcare Conference signifies active engagement within the broader healthcare industry, a common practice for publicly traded companies to communicate strategic direction and updates to the investment community.

Stakeholder Impact

• Shareholders/Investors: Provides advance notice of an upcoming investor presentation that will detail the company's 2026 priorities and strategy, offering insights into future direction.
• Analysts: Offers a scheduled opportunity for direct engagement with company management and access to strategic information for their research and reports.

Next Steps

• Sanara MedTech Inc. will present at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025.

Key Dates

Recommendation

The filing is a routine disclosure of an upcoming investor presentation that will outline the company's 2026 strategy. While investor engagement is positive, the filing itself does not contain new financial results, operational updates, or other material information that would warrant a change in investment recommendation. Investors should await the actual presentation content for more detailed insights.

Keywords

Sanara MedTech, SMTI, Investor Presentation, Healthcare Conference, Regulation FD, Corporate Strategy, 2026 Fiscal Year, SEC Filing